Doximity (DOCS)
(Delayed Data from NYSE)
$66.00 USD
+0.18 (0.27%)
Updated Oct 31, 2025 04:00 PM ET
After-Market: $66.02 +0.02 (0.03%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth F Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, Doximity, Inc. has a PEG ratio of 2.35 compared to the Medical Info Systems industry's PEG ratio of 2.75.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
DOCS 66.00 +0.18(0.27%)
Will DOCS be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for DOCS based on the 1-3 month trading system that more than doubles the S&P 500.

Zacks News for DOCS
Doximity (DOCS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Will Doximity (DOCS) Beat Estimates Again in Its Next Earnings Report?
DOCS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Buy These 5 Health and Fitness Stocks for a Stable Portfolio in Q4
ECL Stock Falls in Pre-Market Despite Q3 Earnings Beat, Margins Expand
Other News for DOCS
Technical picture remains unchanged for DOCS after it rises 0.27% on October 31
Dr. Martens Announces Total Voting Rights Update
DOCS forms Stochastic Reached Oversold on October 30
The S&P 500 Might Be Overheated, but Bank of America Sees Value in These 2 Stocks
Privia Health's Premium: A Breakout Play